Identifying and Caring for Individuals With Inherited Cancer Syndrome
Part of paid clinical trials in Portland, Oregon.
- Sponsor
- OHSU Knight Cancer Institute
- Study ID
- NCT04494945
- Status
- Recruiting
Conditions
- BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
- Breast Ductal Carcinoma In Situ
- Hematopoietic and Lymphoid System Neoplasm
- Hereditary Neoplastic Syndrome
- Lynch Syndrome
- Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Biospecimen Collection — PROCEDUREUndergo collection of saliva sample
- Genetic Counseling — OTHERReceive genetic counseling if testing results are positive
- Genetic Testing — OTHERUndergo genetic testing
- Survey Administration — OTHERComplete a survey
Study Details
This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like hereditary breast and ovarian cancer or Lynch syndromes) instead of only testing people whose families are known to be high risk.
Key Dates
- Start date
- Mar 9, 2020
- Status verified
- Jan 2026
- Primary completion
- Mar 31, 2026
- Completion
- Mar 31, 2026
Study Design
- Enrollment
- 27,500 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Other: Screening (genetic testing)Patients undergo collection of saliva samples for genetic testing. If genetic test is positive, patients receive genetic counseling.
Primary Outcome Measure
Effectiveness and sustainability of heritable cancer syndrome testing in the two novel testing populations [ Time Frame: Up to 5 years ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| OHSU Knight Cancer Institute | Portland | Oregon | 97239 | Jackilen Shannon, Ph.D. (PRINCIPAL_INVESTIGATOR) |
| Providence Portland Medical Center | Portland | Oregon | 97213 | Bill J. Wright, Ph.D. Bill J. Wright, Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Portland, OR
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic MalignanciesPHASE1/PHASE2 · Recruiting · M.D. Anderson Cancer Center · Boston, Massachusetts
- Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid TumorsRecruiting · SWOG Cancer Research Network · Anchorage, Alaska
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting · Alliance for Clinical Trials in Oncology · Anchorage, Alaska